Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194402 · ClinicalTrials.gov registry record · Phase 4
SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT00194402 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 64 participants.
The verdict
NCT00194402, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
Slo-Niacin and atorvastatin (Lipitor) are both drugs that lower cholesterol. In this research, we will compare the effectiveness of Slo-Niacin and atorvastatin taken alone and together. This study will help show how the individual benefits of the two drugs taken separately can be combined when taken together.
Interventions
- DRUG Slo-Niacin, atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2003-08 |
| Est. Completion | 2006-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194402
The ClinicalTrials.gov registry entry for NCT00194402 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Slo-Niacin, atorvastatin is the first listed.
NCT00194402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194402 about?
NCT00194402 is a clinical study titled "SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia". Slo-Niacin and atorvastatin (Lipitor) are both drugs that lower cholesterol. In this research, we will compare the effectiveness of Slo-Niacin and atorvastatin taken alone and together. This study will help show how the individual benefits of the two drugs taken separately can be combined when taken...
What is the current status of trial NCT00194402?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2003-08. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00194402?
The interventions under investigation include: Slo-Niacin, atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00194402?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.